This delayed emptying contributes to prolonged feelings of fullness but can also cause nausea, bloating, and early satiety, particularly during the first few weeks of treatment or after dose escalation
In May, Lilly released trial results showing participants with obesity and without diabetes who stayed on retatrutide for 80 weeks lost an average 28 percent of their weight
Whether youre a veteran or know someone who is, understanding available options empowers you to make informed decisions for sustainable weight management
Last reviewed: June 17, 2026 Last updated: June 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
If your body is still adjusting to treatment or you are eating less than usual, this may affect how well you tolerate the process